Connor, Clark & Lunn Investment Management Ltd.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1596800
VANCOUVER, A1
Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,183,825
+$14,845,354 QoQ
Shares Held
36,269
+434.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#503
of 2,602 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. TMO ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
110,353 | $58,441,845 | |
| 2 | GH |
Guardant Health, Inc.
|
215,395 | $32,315,711 | |
| 3 | DHR |
Danaher Corp /De/
|
114,010 | $21,716,624 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
This page
|
36,269 | $18,183,825 | |
| 5 | NEO |
Neogenomics Inc
|
802,597 | $11,709,889 | |
| 6 | RVTY |
Revvity, Inc.
|
87,145 | $9,695,752 | |
| 7 | MYGN |
Myriad Genetics Inc
|
1,407,860 | $8,038,880 | |
| 8 | CSTL |
Castle Biosciences Inc
|
331,727 | $7,911,688 |
All Filings in TMO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,183,825 | 36,269 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,338,471 | 6,792 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $2,384,843 | 4,917 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $25,471,402 | 62,821 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,805,147 | 7,647 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $19,789,028 | 38,039 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $23,676,385 | 38,276 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $61,430,558 | 111,086 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,677,558 | 26,974 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $270,172 | 509 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,678,651 | 5,292 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $496,254 | 861 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $27,737,704 | 50,369 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $23,238,938 | 45,819 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $25,715,615 | 47,334 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $30,599,213 | 51,806 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $28,270,291 | 42,369 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $33,984,422 | 59,483 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $23,058,819 | 45,709 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $21,488,652 | 47,085 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,173,299 | 2,519 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,280,608 | 36,874 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,277,890 | 33,885 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,679,090 | 20,025 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||